GENEVA, Aug. 7 -- 4M THERAPEUTICS INC. filed a patent application (US2025/038133) for “N-DESMETHYL RUBOXISTAURIN AS A RSK INHIBITOR FOR THERAPEUTIC USE”. With publication no. WO/2026/020045, here are the other details related to the patent application:
Kind: Correction of entry in Section I of the PCT Gazette [A8]
IPC: A61K 31/407
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....